Heart Medication Recall Expands Again
For the second time this month, heart medication recall expands again. Torrent Pharmaceuticals discovered that Losartan, a drug used to treat high blood pressure, a blood pressure-related heart problem and diabetes-related kidney issues tested positive for N-nitrosodiethylamine (NDEA). Now, in addition to the 10 lots of Losartan potassium tablets and six lots of Losartan, the FDA has recalled potassium and hydrochlorothiazide tablets.
NDEA can exist naturally in certain foods and drinking water. However, it can also be in air pollution and industrial processes. Many industry materials also use it along with gasoline as a stabilizer. The International Agency for Research on Cancer warns that it can cause cancer in humans. Now, the FDA has pinpointed that NDEA in these heart medications was made by Zhejiang Huahai Pharmaceutical Company Co. Ltd. The FDA thus placed the Chinese company on an import alert at the end of September. This means all of its active pharmaceutical products and finished products will not be permitted to enter the United States. The FDA made that decision after an inspection of the facility.
More Heart Medications Recalled
Patients use Losartan to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and nephropathy in Type 2 diabetic patients. On January 3rd, Torrent’s first announced a recall of Losartan. Now, the FDA discovered more contaminated lots.
The contaminated lots are:
▪ Losartan Potassium, 100mg, 30-count bottles, lot No. BO31C016
▪ Losartan Potassium, 100mg, 90-count bottles, lot No. BO31C016
▪ Losartan Potassium, 100mg, 1,000-count bottles, lot Nos. 4DK3C004, 4DK3C005, 4DU3C040, 4DU3E049 and 4DU3E050.
▪ Losartan Potassium, 50mg, 30-count bottles, lot No. 4L67C305.
▪ Losartan Potassium, 50mg, 90-count bottles, lot Nos. 4L67C305 and 4L67C306.
▪ Losartan Potassium, 50mg, 1,000-count bottles, lot No. 4O50C005.
▪ Losartan Potassium, 25mg, 90-count bottles, lot No. 4O49C013.
▪ Losartan Potassium Hydrochlorothiazide, 50mg/12.5mg, 90-count, lot No. BP02C008
▪ Losartan Potassium Hydrochlorothiazide, 50mg/12.5mg, 1000-count, lot No. BEF7D006
▪ Losartan Potassium Hydrochlorothiazide, 100mg/12.5mg, 90-count, lot Nos. BX35C020 and BX35C049
▪ Losartan Potassium Hydrochlorothiazide, 100mg/12.5mg, 1000-count, lot Nos. BX35C022 and BX35C023
Many people after taking recalled heart medications are horrified to learn that their blood pressure meds could have caused their liver cancer. Thus, it is important to seek justice. These potentially cancer-causing drugs have been on the market for over 5 years. This is unacceptable. Therefore, you should hold these manufacturers accountable.
We want to help send a message that this is not acceptable. If a dangerous product harmed you, we will be your advocate. Additionally, we have the experience necessary to successfully litigate these cases.
Contact the Michael Brady Lynch Firm today for a free consultation to learn more about seeking justice. Compensation may be available for any medical expenses associated with this ordeal, as well as for your physical and emotional suffering. There is also no obligation.